Skip to main content

Lund University Publications

LUND UNIVERSITY LIBRARIES

Quality of Life, Anxiety and Depressive Symptoms in North Sea–Progressive Myoclonus Epilepsy : A Comparative Analysis With Other Hyperkinetic Movement Disorders

Polet, S. S. ; Bent, T. ; Tijssen, M. A.J. ; de Koning, T. J. LU and Timmers, E. R. (2025) In Acta Neurologica Scandinavica 2025(1).
Abstract

Objectives: North Sea–Progressive Myoclonus Epilepsy (NS-PME) is a rare, childhood-onset disorder primarily characterized by movement disorders including progressive myoclonus and ataxia; subsequently accompanied by varying degrees of epilepsy. While motor symptoms are clearly defined, quality of life (QoL) has never been investigated in NS-PME. Additionally, nonmotor symptoms (NMS) including anxiety, depression, and cognitive problems are known to impact QoL and are increasingly being reported in other movement disorders. Hence, we examined the presence of anxiety and depression symptoms and the degree of QoL in NS-PME. Materials and Methods: Data were collected from multiple cross-sectional, survey-based studies conducted between 2014... (More)

Objectives: North Sea–Progressive Myoclonus Epilepsy (NS-PME) is a rare, childhood-onset disorder primarily characterized by movement disorders including progressive myoclonus and ataxia; subsequently accompanied by varying degrees of epilepsy. While motor symptoms are clearly defined, quality of life (QoL) has never been investigated in NS-PME. Additionally, nonmotor symptoms (NMS) including anxiety, depression, and cognitive problems are known to impact QoL and are increasingly being reported in other movement disorders. Hence, we examined the presence of anxiety and depression symptoms and the degree of QoL in NS-PME. Materials and Methods: Data were collected from multiple cross-sectional, survey-based studies conducted between 2014 and 2020 at the University Medical Center Groningen (UMCG), the Netherlands. First, data on QoL, anxiety, and depression symptoms were collected from 11 persons with NS-PME. Second, to compare outcomes in NS-PME with controls (n = 21) and other hyperkinetic movement disorders (HMDs; n = 146), data from previously conducted studies in the UMCG were reused. The surveys used include the SF-36/RAND-36, the Beck Anxiety Inventory (BAI), and the Beck Depression Inventory (BDI). Results: Symptoms of anxiety and depression were not present in the majority of persons with NS-PME. Compared to QoL scores of controls and other HMDs, persons with NS-PME scored significantly worse on physical functioning domains and, although nonsignificant, rendered the highest scores on emotional functioning domains. Conclusion: Firstly, we did not find indications for significantly increased anxiety or depression symptoms in NS-PME. Secondly, our findings on QoL in NS-PME reveal the following: (1) a floor effect of the SF-36 questionnaire and (2) suggest a disability paradox in NS-PME, in which persons with NS-PME reported good emotional well-being, despite physical challenges. To explore the presence of a disability paradox further and generate more suitable QoL measures for movement disorders such as NS-PME, future studies should elaborate on personal perspectives, including the exploration of coping mechanisms.

(Less)
Please use this url to cite or link to this publication:
author
; ; ; and
organization
publishing date
type
Contribution to journal
publication status
published
subject
keywords
disability paradox, myoclonus ataxia, nonmotor symptoms, North Sea–Progressive Myoclonus Epilepsy, quality of life
in
Acta Neurologica Scandinavica
volume
2025
issue
1
article number
3302536
pages
10 pages
publisher
Wiley-Blackwell
external identifiers
  • scopus:105001009463
ISSN
0001-6314
DOI
10.1155/ane/3302536
language
English
LU publication?
yes
additional info
Publisher Copyright: Copyright © 2025 S. S. Polet et al. Acta Neurologica Scandinavica published by John Wiley & Sons Ltd.
id
2e7728a1-7f02-4e2c-aa23-9c2495fa796c
date added to LUP
2025-04-02 11:02:59
date last changed
2025-04-04 15:31:49
@article{2e7728a1-7f02-4e2c-aa23-9c2495fa796c,
  abstract     = {{<p>Objectives: North Sea–Progressive Myoclonus Epilepsy (NS-PME) is a rare, childhood-onset disorder primarily characterized by movement disorders including progressive myoclonus and ataxia; subsequently accompanied by varying degrees of epilepsy. While motor symptoms are clearly defined, quality of life (QoL) has never been investigated in NS-PME. Additionally, nonmotor symptoms (NMS) including anxiety, depression, and cognitive problems are known to impact QoL and are increasingly being reported in other movement disorders. Hence, we examined the presence of anxiety and depression symptoms and the degree of QoL in NS-PME. Materials and Methods: Data were collected from multiple cross-sectional, survey-based studies conducted between 2014 and 2020 at the University Medical Center Groningen (UMCG), the Netherlands. First, data on QoL, anxiety, and depression symptoms were collected from 11 persons with NS-PME. Second, to compare outcomes in NS-PME with controls (n = 21) and other hyperkinetic movement disorders (HMDs; n = 146), data from previously conducted studies in the UMCG were reused. The surveys used include the SF-36/RAND-36, the Beck Anxiety Inventory (BAI), and the Beck Depression Inventory (BDI). Results: Symptoms of anxiety and depression were not present in the majority of persons with NS-PME. Compared to QoL scores of controls and other HMDs, persons with NS-PME scored significantly worse on physical functioning domains and, although nonsignificant, rendered the highest scores on emotional functioning domains. Conclusion: Firstly, we did not find indications for significantly increased anxiety or depression symptoms in NS-PME. Secondly, our findings on QoL in NS-PME reveal the following: (1) a floor effect of the SF-36 questionnaire and (2) suggest a disability paradox in NS-PME, in which persons with NS-PME reported good emotional well-being, despite physical challenges. To explore the presence of a disability paradox further and generate more suitable QoL measures for movement disorders such as NS-PME, future studies should elaborate on personal perspectives, including the exploration of coping mechanisms.</p>}},
  author       = {{Polet, S. S. and Bent, T. and Tijssen, M. A.J. and de Koning, T. J. and Timmers, E. R.}},
  issn         = {{0001-6314}},
  keywords     = {{disability paradox; myoclonus ataxia; nonmotor symptoms; North Sea–Progressive Myoclonus Epilepsy; quality of life}},
  language     = {{eng}},
  month        = {{03}},
  number       = {{1}},
  publisher    = {{Wiley-Blackwell}},
  series       = {{Acta Neurologica Scandinavica}},
  title        = {{Quality of Life, Anxiety and Depressive Symptoms in North Sea–Progressive Myoclonus Epilepsy : A Comparative Analysis With Other Hyperkinetic Movement Disorders}},
  url          = {{http://dx.doi.org/10.1155/ane/3302536}},
  doi          = {{10.1155/ane/3302536}},
  volume       = {{2025}},
  year         = {{2025}},
}